Nanolive launches the LIVE Cell Death Assay

A push-button, automated solution for profiling cell health and death

Nanolive launches another ground-breaking tool in cell analysis: the LIVE Cell Death Assay, a push button, automated solution for profiling cell health, death, apoptosis and necrosis, label-free.

The LIVE Cell Death Assay (LCDA) provides first-in-class cytotoxicity analysis of dynamic label-free live cell data. Developed using state-of-the-art machine learning, the LCDA has been trained to discriminate not only living cells from dead cells, but also apoptosis from necrosis.

The LCDA has been created to be as user-friendly as possible: a single click of a button is required to launch the analysis. It delivers 13 viability and death-related metrics.

Watch the LIVE Cell Death Assay product video below!

Read our latest news

Newsletter October 2024: Investigative toxicology without labels

Newsletter October 2024: Investigative toxicology without labels

Welcome to the October edition of the AI for Live Cell Insights Newsletter, bringing you the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live...

September 2024: High-content imaging for kidney disease research

September 2024: High-content imaging for kidney disease research

Welcome to the September edition of the AI for Live Cell Insights Newsletter, bringing you the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of cellular analysis for label-free live cell...